GSK swine flu drug approved in US: company

British drug maker GlaxoSmithKline has announced that US regulators have approved its swine flu vaccine for adults in the United States.

"The US Food and Drug Administration (FDA) has approved a... license application for its unadjuvanted influenza A (H1N1) pandemic vaccine," GSK said in a statement received on Wednesday.

"The United States Department of Health and Human Services has placed an order to fill 7.6 million doses of unadjuvanted H1N1 pandemic vaccine from GSK, which will contribute to the approximately 250 million doses secured by the US government."

Although the is used to fight swine flu, its make-up is different to Pandemrix -- GSK's drug recently approved by EU regulators to treat in Europe.

(c) 2009 AFP


Explore further

Sanofi to deliver swine flu vaccine in October

Citation: GSK swine flu drug approved in US: company (2009, November 11) retrieved 25 February 2020 from https://medicalxpress.com/news/2009-11-gsk-swine-flu-drug-company.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments